Tenders
Cardiovascular drug tenders in France
Cardiovascular drug tenders in France: 373 listed on GranTender since 2024; 1 open now. The median awarded contract value is about €1,300,000 (42 contracts with a stated value). Buyers with the most tenders: Centre Hospitalier Universitaire Caen Normandie (147), CHU Rouen Normandie (137) and Centre Hospitalier Universitaire de Reims, en qualité d'établissement support du Groupement Hospitalier Universitaire de Champagne (GHUC) (55); suppliers with the most contract awards: Abbott Medical France (26), Takeda France (25) and LFB Biomedicaments (24). Sources: DECP, BOAMP and TED. In 2025 the median contract value was €390,000; 1% of contracts drew a single bid (69.7 bids on average). Data as of 18 November 2026; updated daily.
- Tenders
- 373
- Open tenders
- 1
- Awards
- 439
- Awarded value awarded
- €322,274,598
- Awarded value contract
- €748,487,204
- Awarded value framework ceiling
- €341,621,598
- Median contract value contract
- ≈ €410,000
- Median contract value awarded
- ≈ €1,300,000
- Median contract value framework ceiling
- ≈ €1,600,000
- Average bids per contract
- 51.1
- Tenders in 2025
- 210 +1,300% on 2024
Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.
Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.
Open tenders
| Tender | Buyer | Estimated value | Status | Published |
|---|---|---|---|---|
| UNIHA Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie Génique | Hospices Civils de Lyon | — | Open | 19 November 2025 |
Latest tenders
Top buyers
- Centre Hospitalier Universitaire Caen Normandie147
- CHU Rouen Normandie137
- Centre Hospitalier Universitaire de Reims, en qualité d'établissement support du Groupement Hospitalier Universitaire de Champagne (GHUC)55
- CHU de Toulouse9
- 29 CHRU6
- CHRU de Tours3
- CHU de Limoges2
- Hopital Nord Ouest - Villefranche sur Saone2
- CHU d'Angers1
- 1
Top winners
Competition and prices
In 2025, half of the contracts were worth between €100,000 and €1.8 million, with a median of €390,000 (204 contracts with a stated contract value). Contracts drew 69.7 bids on average (median 72) and 1% drew a single bid — based on 148 contracts with a known number of bids.
The most contracts went to Abbott Medical France (26), Takeda France (25) and LFB Biomedicaments (24) — together 17% of all contracts.
| Year | Contracts | Median value | Middle half of values | Bids on average | Single bid |
|---|---|---|---|---|---|
| 2025 | 208 | €390,000 (contract value) | €100,000 – €1.8 million | 69.7 | 1% (148) |
| 2026 (so far) | 146 | €430,000 (contract value) | €150,000 – €870,000 | — | — |
| All years | 439 | €410,000 (contract value) | €120,000 – €1.3 million | 51.1 | 1% (224) |
Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.
Where you have a chance
Since 1 November 2024, 2% of the 152 contracts with a known number of bids had a single bid; the median was 72 bids. The number of bids is known for 152 of the 353 contracts from procedures with competition.
In the last 12 months, 2 companies won their first contract in our records here — 1% of the 140 contracts (our records start on 1 January 2024).
Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.
Main CPV divisions
CPV codes of this topic
A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.
Cardiovascular and anticoagulant drugs in neighbouring countries
Today, 2 tenders in the same niche are open in neighbouring countries.
- Spain — 1 open today · how to bid in Spain
- Belgium — 1 open today
- Italy — 0 open today · how to bid in Italy
Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.
Expected soon2
| Expected | Buyer | What | Why we expect it | Confidence |
|---|---|---|---|---|
| Dec 2026 – May 2027 | CHU de Lille - ES du GHT HPGL | Cardiovascular and anticoagulant drugs | The current contract with KEDRION BIOPHARMA INC ends on 18 June 2027 (from its stated duration); no new tender has been published yet. | medium |
| Dec 2026 – May 2027 | Hopital Nord Ouest - Villefranche sur Saone | Cardiovascular and anticoagulant drugs | The current contract with SANDOZ ends on 19 June 2027 (from its stated duration); no new tender has been published yet. | high |
Forecast from public data, not an announcement. Methodology.
Market reports
Cardiovascular and anticoagulant drugs by city
Cardiovascular and anticoagulant drugs in other countries
Cardiovascular and anticoagulant drugs across Europe
Topics in Health, medical equipment and medicines
Questions and answers
- Which cardiovascular drug tenders in France are open now?
- 1 of the 373 cardiovascular drug tenders in France listed on GranTender is open for bids. For example: UNIHA Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie Génique.
- Where can I find cardiovascular drug tenders in France?
- GranTender lists them in one place, from DECP, BOAMP and TED, with their buyers, winners and contract values; 1 is open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
- Who wins the most cardiovascular drug tenders in France?
- By number of contracts won: Abbott Medical France (26), Takeda France (25), LFB Biomedicaments (24).
- Which buyers publish the most cardiovascular drug tenders in France?
- By number of tenders: Centre Hospitalier Universitaire Caen Normandie (147), CHU Rouen Normandie (137), Centre Hospitalier Universitaire de Reims, en qualité d'établissement support du Groupement Hospitalier Universitaire de Champagne (GHUC) (55).
- Which CPV codes belong to “Cardiovascular and anticoagulant drugs”?
- 33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system; plus tenders without a usable CPV code whose title names the topic.
- How many bids do cardiovascular drug tenders in France receive on average?
- In 2025, contracts drew 69.7 bids on average (median 72) and 1% drew a single bid — based on 148 contracts with a known number of bids.
- How much are contracts for cardiovascular drug tenders in France worth?
- In 2025, half of the contracts were worth between €100,000 and €1.8 million, with a median of €390,000 (204 contracts with a stated contract value).
CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.